Search clinical trials for: Relapsed AML
Total 7384 results
-
ADC Therapeutics S.A.TerminatedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Lai Corporation Pty. Ltd.UnknownAcute Myeloid Leukaemia RecurrentThailand
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedRelapsed Acute Myelogenous LeukemiaUnited States
-
Daiichi Sankyo Co., Ltd.Daiichi Sankyo, Inc.Completed
-
Novartis PharmaceuticalsWithdrawnLeukemia, Myeloid, Acute
-
CelgeneCompletedLeukemia, MyeloidUnited States, Canada
-
Fujian Medical UniversityUnknown
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States, France, Italy, United Kingdom
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid LeukemiaUnited States, Spain, Netherlands, Canada, France, Germany, United Kingdom, Italy, Poland
-
Washington University School of MedicineCantex PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | AML | MDSUnited States
-
PfizerTerminatedAcute Myeloid LeukemiaUnited States
-
Genentech, Inc.Completed
-
M.D. Anderson Cancer CenterEli Lilly and Company; High Impact Clinical Research Support ProgramCompleted
-
M.D. Anderson Cancer CenterIntrexon CorporationTerminatedAcute Myeloid Leukemia | Hematopoietic/Lymphoid CancerUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
ImmunoGen, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Sun Yat-sen UniversityUnknownAcute Myeloid Leukemia | Relapse LeukemiaChina
-
PfizerNo longer availableCD33 Positive Acute Myelogenous LeukemiaUnited States
-
Cyclacel Pharmaceuticals, Inc.M.D. Anderson Cancer CenterUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedLeukemia | AML | CML | Myeloid LeukemiasUnited States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyTerminatedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Io TherapeuticsTerminatedAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States
-
Institute of Hematology & Blood Diseases HospitalUnknownAcute Myeloid LeukemiaChina
-
University of California, San DiegoPfizer; Celgene CorporationCompletedAcute Myeloid LeukemiaUnited States
-
Institut CurieNational Cancer Institute, France; Fondation ARCTerminatedAcute Myeloid Leukemia, in Relapse | Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome | de Novo Acute Myeloid Leukemia at DiagnosticFrance
-
Northwestern UniversityTerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Arog Pharmaceuticals, Inc.WithdrawnRelapsed/Refractory FLT3-mutated AML
-
Astellas Pharma IncCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Immunex CorporationWithdrawnAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia
-
Michael LuebbertUniversity Hospital FreiburgUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromeGermany
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals; Celgene CorporationCompleted
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Seattle Children's HospitalChildren's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...CompletedAML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDSUnited States, Canada
-
Sunesis PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Canada, Spain, Belgium, Korea, Republic of, Australia, France, Germany, Poland, New Zealand, United Kingdom, Czechia, Austria, Hungary, Italy
-
Nanfang Hospital of Southern Medical UniversityEnrolling by invitationAcute Myeloid Leukemia | FLT3-ITD Mutation | Brutons Tyrosine KinaseChina
-
Agios Pharmaceuticals, Inc.Approved for marketingAcute Myeloid Leukemia | Relapsed Pediatric AML | Relapsed Adult AML
-
University of WashingtonNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterEisai Inc.CompletedLeukemiaUnited States
-
M.D. Anderson Cancer CenterJazz PharmaceuticalsWithdrawn
-
The Affiliated Hospital of the Chinese Academy...Unknown
-
Children's Hospital Medical Center, CincinnatiAstellas Pharma IncTerminatedCancer | Immunocompromised | Bone Marrow TransplantUnited States
-
Jazz PharmaceuticalsWithdrawnAcute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS)United States
-
St. Jude Children's Research HospitalTerminatedAcute Myeloid Leukemia | Acute Lymphoid Leukemia | Mixed Lineage Acute LeukemiaUnited States
-
Justin WattsMinneamrita Therapeutics LLCWithdrawnAcute Myeloid Leukemia
-
Alison Sehgal, MD, MSTerminatedLeukemia, Acute MyelogenousUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myelogenous LeukemiaUnited States